中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
—— |
(3R,4S)-tert-butyl 3-(((S)-N-((R)-(1-benzyl-4-(2,5-difluorophenyl)-1H-imidazol-2-yl)(tetrahydro-2H-pyran-4-yl)methyl)-2-((tert-butyldimethylsilyl)oxy)propanamido)methyl)-4-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate |
—— |
C42H60F2N4O8SSi |
|
—— |
3-tetrazolo-3,5-androstadien-17-one |
—— |
C20H26N4O |
|
—— |
3-(trifluoromethoxy)benzyl acetate |
—— |
C10H9F3O3 |
|
—— |
3-ethyl 5-benzyl-2-methyl-4-phenylethynyl-6-cyclopentylpyridine-3,5-dicarboxylate |
—— |
C30H29NO4 |
|
—— |
(3β)-25-<<(1,1-Dimethylethyl)dimethylsilyl>oxy>-3-<<dimethyl(1,1,2-trimethylpropyl)silyl>oxy>cholesta-5,7,16-trien-23-yn-22-ol |
—— |
C41H70O3Si2 |
|
—— |
(3R,6S)-2-Benzyl 1-methyl 3,6-dimethyl-1,4-cyclohexadiene-1,2-dicarboxylate |
—— |
C18H20O4 |
|
—— |
3'-O-[1-(2,4-dichlorobenzyl)-1H-indazole-3-carbonyl]-5-fluoro-2'-deoxyuridine |
—— |
C24H19Cl2FN4O6 |
|
—— |
3-chloro-4-[4-[5-(2-pyrimidinyl)piperidin-1-yl]butyl]-1,4-benzoxazepin-5(4H)-one |
—— |
C22H25ClN4O2 |
|
—— |
3-chloro-4,5-dihydro-4-(4-(4-(pyridin-2-yl)piperidin-1-yl)butyl)-1,4-benzoxazepin-5-one |
—— |
C23H26ClN3O2 |
|
—— |
3-chloro-4,5-dihydro-4-(4-(4-(2-pyrimidinyl)-1,2,3,6-tetrahydropyridin-1-yl)butyl)-1,4-benzoxazepin-5-one |
—— |
C22H23ClN4O2 |
|
—— |
3-chloro-4-[4-[4-hydroxy-4-(2-pyrimidinyl)piperazin-1-yl]butyl]-1,4-benzoxazepin-5(4H)-one |
—— |
C22H25ClN4O3 |
|
—— |
3-chloro-4,5-dihydro-4-(4-(3-(2-pyrimidinyl)-1,2,5,6-tetrahydropyridin-1-yl)butyl)-1,4-benzoxazepin-5-one |
—— |
C22H23ClN4O2 |
|
—— |
3,6-dioxo-17α-pregnane 21,17-carbolactone |
—— |
C22H30O4 |
|
—— |
3-chloro-4-[4-[4-(2-pyrimidinyl)piperidin-1-yl]butyl]-1,4-benzoxazepin-5(4H)-one |
—— |
C22H25ClN4O2 |
|
—— |
3β-hydroxy-17-(2H-tetrazol-2-yl)androsta-5,16-diene |
—— |
C20H28N4O |
|
—— |
3β-hydroxy-17-(2H-1,2,3-triazol-2-yl)androsta-5,16-diene |
—— |
C21H29N3O |
|
—— |
3β-hydroxy-17-(1H-pyrazol-1-yl) androsta-5,16-diene |
—— |
C22H30N2O |
|
—— |
(3S,4R)-1-(t-butyldimethylsilyl)-3-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-4-(3-benzyloxycarbonyl-2-hydroxypropyl)azetidin-2-one |
—— |
C28H49NO5Si2 |
|
—— |
3-methyl-4-[4-[4-(2-pyrimidinyl)piperazin-1-yl]butyl]-1,4-benzoxazepin-5(4H)-one |
—— |
C22H27N5O2 |
|
—— |
3-chloro-4,5-dihydro-4-(4-(4-(pyridin-2-yl)piperazin-1-yl)butyl)-1,4-benzoxazepin-5-one |
—— |
C22H25ClN4O2 |
|
—— |
3-chloro-4-[4-[4-(2-pyrimidinyl)piperazin-1-yl]butyl]-1,4-benzoxazepin-5(4H)-one |
—— |
C21H24ClN5O2 |
|
—— |
3H-1,2-dithiole |
288-26-6 |
C3H4S2 |
|
—— |
3-(2',3',4'-trithia-6'-heptenyl)-3,4-dihydro-2H-thiopyran |
—— |
C9H14S4 |
|
—— |
3-[(Z)-1-(trimethylsilyloxy)-1-propenyl]spiro[2H-1,3-benzoxazine-2,1'-cyclohexan]-4-(3H)-one |
—— |
C19H27NO3Si |
|
—— |
3-<(2R)-2-<(3S,4R)-3-<(1R)-1-(tert-butyldimethylsilyloxy)ethyl>-2-oxoazetidin-4-yl>propionyl>-2,2-dibutyl-2,3-dihydro-4H-1,3-benzoxazin-4-one |
—— |
C30H48N2O5Si |
|
—— |
3-O-acetylresveratrol |
—— |
C16H14O4 |
|
—— |
3-<(2R)-2-<(3S,4R)-3-<(1R)-1-(tert-butyldimethylsilyloxy)ethyl>-2-oxoazetidin-4-yl>propionyl>spiro<2,3-dihydro-4H-1,3-benzoxazine-2,1'-cyclopentan>-4-one |
—— |
C26H38N2O5Si |
|
—— |
3-<(2S)-2-<(3S,4R)-3-<(1R)-1-(tert-butyldimethylsilyloxy)ethyl>-2-oxoazetidin-4-yl>propionyl>2,3-dihydro-2,2-dimethyl-4H-1,3-benzoxazin-4-one |
—— |
C24H36N2O5Si |
|
—— |
3-<(2S)-2-<(2R,3S)-3-<(1R)-1-(tert-Butyldimethylsiloxy)ethyl>-4-oxoazetidin-2-yl>propionyl>spiro-<2,3-dihydro-4H-1,3-benzoxazine-2,1'-cyclohexan>-4-one |
—— |
C27H40N2O5Si |
|
—— |
3-<(2R)-2-<(3S,4R)-3-<(1R)-1-(tert-butyldimethylsilyloxy)ethyl>-2-oxoazetidin-4-yl>propionyl>2,3-dihydro-2,2-dimethyl-4H-1,3-benzoxazin-4-one |
—— |
C24H36N2O5Si |
|
—— |
3,5-di-O-acetylresveratrol |
1246833-37-3 |
C18H16O5 |
|
—— |
3-<(2R)-2-<(3S,4R)-3-<(1R)-1-(tert-butyldimethylsilyloxy)ethyl>-2-oxoazetidin-4-yl>propionyl>-2,2-dibenzyl-2,3-dihydro-4H-1,3-benzoxazine-4-one |
—— |
C36H44N2O5Si |
|
—— |
3-(2-bromopropionyl)-2,3-dihydro-2,2-dimethyl-4H-1,3-benzoxazin-4-one |
—— |
C13H14BrNO3 |
|
—— |
3-ethoxy-5,4'-dihydroxystilbene |
—— |
C16H16O3 |
|
—— |
3,5,4'-[2,2-bis(hydroxymethyl)propanoxy]resveratrol |
—— |
C29H36O12 |
|
—— |
3,4'-diethoxy-5-hydroxystilbene |
—— |
C18H20O3 |
|
—— |
3,5-diacetyl-4'-[2,2-bis(hydroxymethyl)propanoxy]-resveratrol |
—— |
C23H24O8 |
|
—— |
3-(tert-butoxycarbonylamino)-2-fluoropropanoic acid |
—— |
C8H14FNO4 |
|
—— |
3,5,4'-tri-opalmitoylresveratrol |
—— |
C68H114O6 |
|
—— |
3-acetyl-5,4'-[2,2-bis(hydroxymethyl)propanoxy]resveratrol |
—— |
C26H30O10 |
|
—— |
3,4'-[2,2-bis(hydroxymethyl)propanoxy]resveratrol |
—— |
C24H28O9 |
|
—— |
3-(imidazo[1,5-a]pyridin-8-ylmethoxy)isonicotinaldehyde |
—— |
C14H11N3O2 |
|
—— |
3-((4-(4-chlorobenzyl)piperazin-1-yl)methyl)-5-(pyridin-3-yl)-1,3,4-oxadiazole-2(3H)-thione |
—— |
C19H20ClN5OS |
|
—— |
3-((4-(pyridin-2-yl)piperazin-1-yl)methyl)-5-(pyridin-3-yl)-1,3,4-oxadiazole-2(3H)-thione |
—— |
C17H18N6OS |
|
—— |
3-(5-((2-nicotinoylhydrazono)methyl)furan-2-yl)benzoic acid |
—— |
C18H13N3O4 |
|
—— |
3-carbethoxy-12-cyanoindolizino<2,3-b>quinoxaline |
—— |
C18H12N4O2 |
|
—— |
3-Ethoxycarbonyl-1-(1-phenylvinyl)pyridinium bromide |
—— |
Br*C16H16NO2 |
|
—— |
3,5,4'-resveratrol trilipoate |
—— |
C38H48O6S6 |
|
—— |
3-methyl-4-[2-(3-pyridineformamido)ethoxycarbonyl]furoxan |
—— |
C12H12N4O5 |
|
—— |
3,4',5-tri-[N-(2,2-dimethyl-1,3-dioxolane-4-methan)-carbamoyl]-resveratrol |
—— |
C35H45N3O12 |
|